The Prevalence and Incidence of Different Lung Parenchymal Changes on CT Chest Caused By COVID Pneumonia through Follow Up Course
Main Article Content
Keywords
SARS‐CoV‐2, COVID-19, CT chest, RT-PCR, GGO, TSS, CXR.
Abstract
COVID-19 pneumonia episodes had been present in Wuhan, China, since December 2019. It looks like ground glass lesions, consolidation patches, and sometimes alveolar exudates with interlobular involvement. Chest CT can show these signs before (RT-PCR) and is considered a gold standard for affirming COVID-19 recently. Purpose: We aimed to evaluate the relevance and value of chest CT in diagnosing and following up with the disease. Materials and Methods: A cross-sectional, retrospective study in the radiology department at Badr University Hospitals. 60 individuals were included in the 6-month study, which lasted from September 2021 to March 2022. Initial imaging was taken with follow-up imaging after 6 weeks in most cases. A third CT was due to the disease severity, and two of them had an earlier. Multi-detector CT chest obtained with 1 mm thick without an inter-slice gap. Results: There were 45% men and 55% females. For CT abnormalities there were 90% of cases showed GGO, 63.3% with vascular enlargement, 26.5% for traction bronchiectasis, and the lowest percentages were for sub-pleural lines (3.3%). There were a statistically significant decrease in GGO cases with (p-value= 0.03) and an increase in the sub-pleural line with a p-value of 0.01 on follow-up. A significant increase in the percentage of completely free CT patients in CTSS grades was seen on follow-up with (p-value =0.04). Conclusion: CT chest can help in following up with the patients and predicting the course of the disease according to the visualized signs of lung parenchyma
References
2. Hopkins J. corona virus Resource University Center. School of Medicine. Available from: https://coronavirus.jhu.edu/. 2020.
3. Kim H, Hong H, Yoon SH. Diagnostic performance of CT and reverse transcriptase polymerase chain reaction for coronavirus disease 2019: a meta-analysis. Radiology 2020;296:E145–E155.
4. WHO Coronavirus disease 2019 (COVID-19) Situation. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200315-sitrep-55-covid-19.pdf?sfvrsn=33daa5cb_8. 2020;55.
5. Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382:1708–1720.
6. Pan F, Ye T, Sun P, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology.
7. Wasilewski PG, Mruk B, Mazur S, et al. COVID-19 severity scoring systems in radiological imaging - a review. Polish J Radiol 2020;85:e361–e368.
8. López-Cabrera JD, Orozco-Morales R, Portal-Díaz JA, et al. Current limitations to identify covid-19 using artificial intelligence with chest x-ray imaging (part ii). The shortcut learning problem. Health Technol (Berl) 2021;11:1331–1345.
9. http://en.nhc.gov.cn/. The National Health Commission of the People’s Republic of China.
10. Jędrusik P, Gaciong Z, Sklinda K, et al. Diagnostic role of chest computed tomography in coronavirus disease 2019. Polish Arch Intern Med . Epub ahead of print 2020. DOI: 10.20452/pamw.15348.
11. Bernheim A, Mei X, Huang M, et al. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology 2020;295:200463.